NRX PharmaceuticalsNRXP
13F holders, Q1 2025 (March 31)22holders −3
4new positions
7sold out
$2.04avg. 13F price*
At the end of Q1 2025, 22 institutions reported holding NRX Pharmaceuticals Inc. (NRXP) in their 13F filings, down 3 from Q4 2024. 4 opened new positions and 7 sold out. The largest holders were Anson Funds Management LP ($2.4M), Vanguard Group Inc. ($797K) and AdvisorShares Investments LLC ($556K).
- Company
- NRX Pharmaceuticals Inc.
- CUSIP
- 629444209
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q4 2024 → Q1 2025
| Institutions | Total Value | |
|---|---|---|
| New Positions | 4 | $307K |
| Exits | 7 | $332K |
All 13F filers, Q4 2024 → Q1 2025: 1,386,794 shares bought and 174,912 shares sold, net +1,211,882 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 22 holders
| Anson Funds Management LP | 0.58% | Add +535.1% | 1,179,061 | $2.4M |
| Vanguard Group Inc. | 0.00% | Add +61.8% | 388,925 | $797K |
| AdvisorShares Investments LLC | 0.11% | Reduce -7.6% | 286,797 | $556K |
| Geode Capital Management, LLC | 0.00% | Add +81.3% | 134,657 | $276K |
| Marshall Wace, LLP | 0.00% | New | 89,086 | $183K |
| State Street Corp. | 0.00% | Add +161.4% | 43,724 | $90K |
| Two Sigma Investments, LP | 0.00% | New | 30,146 | $62K |
| BlackRock, Inc. | 0.00% | No change | 29,075 | $60K |
| Northern Trust Corp. | 0.00% | New | 28,601 | $59K |
| One Wealth Management Investment & Advisory Services, LLC | 0.05% | No change | 15,041 | $31K |
| Townsquare Capital LLC | 0.00% | No change | 15,041 | $31K |
| Morgan Stanley | 0.00% | Add +170.6% | 11,896 | $24K |
| Bank of America Corp. | 0.00% | Add +1.4% | 3,343 | $7K |
| Wells Fargo & Company | 0.00% | No change | 2,160 | $4K |
| SBI Securities Co., Ltd. | 0.00% | New | 2,000 | $4K |
| Simplex Trading, LLC | 0.00% | Reduce -36.8% | 633 | $1K |
| UBS Group AG | 0.00% | Reduce -30.0% | 105 | $215 |
| Osaic Holdings, Inc. | 0.00% | No change | 90 | $184 |
| Carolina Wealth Advisors, LLC | 0.00% | No change | 50 | $103 |
| FMR LLC | 0.00% | Reduce -75.3% | 37 | $76 |
| JPMorgan Chase & Co. | 0.00% | Reduce -35.9% | 34 | $70 |
| Larson Financial Group LLC | 0.00% | No change | 22 | $45 |
"% of holder's portfolio" is NRXP's weight in each manager's 13F, not the share of NRX Pharmaceuticals Inc. the manager owns.